INC cozies up to site group; Gallus inks an ADC deal;

> INC Research has deepened its ties with the Society for Clinical Research Sites, a trade organization representing more than 1,500 R&D outposts in 37 countries. More

> CMO Gallus BioPharmaceuticals has signed a deal with Progenics Pharmaceuticals to manufacture armed antibody candidates for clinical development. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.